{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:06Z","timestamp":1793090226714,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105621","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:34:33Z","timestamp":1790404473000},"page":"105621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ADAR1 promotes cancer fitness by buffering endogenous RNA sensing"],"prefix":"10.1016","volume":"227","author":[{"given":"Cristina","family":"Cerboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Petrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Emanuela","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Antonangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10142-025-01611-3","article-title":"3 \u2019 UTR RNA editing driven by ADAR1 modulates MDM2 expression in breast cancer cells","volume":"25","author":"Almeric","year":"2025","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.critrevonc.2026.105621_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116151","article-title":"Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival","volume":"44","author":"\u00c1lvarez-Prado","year":"2025","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 Expression by NF-\u03baB in Cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105621_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1218105","article-title":"Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells","volume":"5","author":"Antonangeli","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12885-025-14098-9","article-title":"Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer","volume":"25","author":"Ayerbes","year":"2025","journal-title":"BMC Cancer Apr 21"},{"key":"10.1016\/j.critrevonc.2026.105621_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.tig.2022.03.013","article-title":"ADAR1 and its implications in cancer development and treatment","volume":"38","author":"Baker","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.critrevonc.2026.105621_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"71","author":"Bass","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105621_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.molcel.2019.02.021","article-title":"ADAR1: A New Target for Immuno-oncology Therapy","volume":"73","author":"Bhate","year":"2019","journal-title":"Mol. Cell."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105621_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells13151257","article-title":"ADAR1 Is Essential for Smooth Muscle Homeostasis and Vascular Integrity","volume":"13","author":"Cai","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105621_bib10","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1038\/s41467-025-62309-5","article-title":"Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1\/2-mutant cancers","volume":"16","author":"Chabanon","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41594-025-01736-w","article-title":"Redox-driven ADAR1 activation promotes Okazaki fragment maturation and DNA replication integrity","volume":"33","author":"Chen","year":"2026","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2026.2677975","article-title":"ADAR1-circRAB5A-BIP axis governs radiotherapy resistance in colorectal cancer through coordinating protective autophagy and apoptosis","volume":"27","author":"Chen","year":"2026","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41467-022-30604-0","article-title":"RNase H2, mutated in Aicardi-Gouti\u00e8res syndrome, resolves co-transcriptional R-loops to prevent DNA breaks and inflammation","volume":"13","author":"Cristini","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105621_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biology9120485","article-title":"The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases","volume":"9","author":"Cuollo","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.critrevonc.2026.105621_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41577-023-00940-3","article-title":"Novel insights into double-stranded RNA-mediated immunopathology","volume":"24","author":"de Reuver","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib19","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.ymthe.2023.04.011","article-title":"Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade","volume":"31","author":"Ding","year":"2023","journal-title":"Mol. Ther."},{"issue":"52","key":"10.1016\/j.critrevonc.2026.105621_bib20","doi-asserted-by":"crossref","first-page":"86161","DOI":"10.18632\/oncotarget.13354","article-title":"Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR \/ p70S6K signaling","volume":"7","author":"Dou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105621_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature24050","article-title":"Cytoplasmic chromatin triggers inflammation in senescence and cancer","volume":"550","author":"Dou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib23","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","article-title":"The novel mechanism of lenalidomide activity","volume":"126","author":"Fink","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105621_bib24","first-page":"123","article-title":"ADARs and editing: The role of A-to-I RNA modification in cancer progression","volume":"2018","author":"Fritzell","year":"2018"},{"key":"10.1016\/j.critrevonc.2026.105621_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105621_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia","volume":"153","author":"Galbraith","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105621_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07824-4","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nat. Cell. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105621_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004974","article-title":"Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer","volume":"10","author":"Gomez","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10715","article-title":"The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis","volume":"7","author":"Gumireddy","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105621_bib31","article-title":"ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway","volume":"5","author":"Guo","year":"2022","journal-title":"Life Sci. Alliance Mar."},{"key":"10.1016\/j.critrevonc.2026.105621_bib32","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-Then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105621_bib33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41556-022-00959-z","article-title":"ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16INK4a levels","volume":"24","author":"Hao","year":"2022","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib34","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41598-023-29397-z","article-title":"ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer","volume":"13","author":"Hata","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib35","doi-asserted-by":"crossref","unstructured":"He, D., Bai, R., Chen, N., 2024. ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK \/ AKT Pathway in Colorectal Cancer 2401\u20132413. https:\/\/doi.org\/10.1002\/mc.23818.","DOI":"10.1002\/mc.23818"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105621_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jitc-2022-005704","article-title":"Z-DNA enhances immunotherapy by triggering death of inflammatory cancer-associated fibroblasts","volume":"10","author":"Herbert","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-04896-7","article-title":"ADAR1 mutation causes ZBP1-dependent immunopathology","volume":"607","author":"Hubbard","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111571","article-title":"Fusion circRNA F-circEA1 facilitates EML4-ALK1 positive lung adenocarcinoma progression through the miR-4673\/SMAD4\/ADAR1 axis","volume":"127","author":"Huo","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.critrevonc.2026.105621_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","article-title":"Double-Stranded RNA Sensors and Modulators in Innate Immunity","volume":"37","author":"Hur","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218071","article-title":"Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I\/MDA5-MAVS pathway","volume":"635","author":"Jia","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105621_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-022-04878-9","article-title":"ADAR1 averts fatal type I interferon induction by ZBP1","volume":"607","author":"Jiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12964-023-01465-x","article-title":"The role of ADAR1 through and beyond its editing activity in cancer","volume":"22","author":"Jiao","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105621_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2023.01.001","article-title":"ADAR1 and ZBP1 in innate immunity, cell death, and disease","volume":"44","author":"Karki","year":"2023","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105621_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109858","article-title":"ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis","volume":"37","author":"Karki","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib46","first-page":"1107","article-title":"DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies","volume":"152","author":"Knuutila","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17773-0","article-title":"RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer","volume":"12","author":"Komatsu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib49","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/s41467-017-01890-w","article-title":"Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma","volume":"8","author":"Lazzari","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25687","article-title":"Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line","volume":"6","author":"Li","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.critrevonc.2026.105621_bib51","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.7150\/jca.61031","article-title":"Targeting ADAR1 suppresses progression and peritoneal metastasis of gastric cancer through Wnt \/ \u03b2-catenin pathway","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700129","article-title":"The Other Face of an Editor: ADAR1 Functions in Editing-Independent Ways","volume":"39","author":"Licht","year":"2017","journal-title":"BioEssays"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105621_bib53","article-title":"Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment","volume":"11","author":"Lin","year":"2023","journal-title":"J. Immunother. Cancer Nov."},{"key":"10.1016\/j.critrevonc.2026.105621_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105621_bib55","article-title":"8-Chloroadenosine suppresses hepatocellular carcinoma progression via ADAR1\/PPAR\u03b3 axis-mediated lipid metabolism","author":"Liu","year":"2025","journal-title":"Genes. Dis."},{"key":"10.1016\/j.critrevonc.2026.105621_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-019-1300-2","article-title":"ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105621_bib57","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1038\/s41467-024-51363-0","article-title":"Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells","volume":"15","author":"L\u00f3pez-Polo","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105621_bib58","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847107","article-title":"ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1\u03b1-inhibiting factors","volume":"20","author":"Ma","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib60","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-cellbio-101323-020352","article-title":"ADAR1: Beyond Just an RNA Editor","volume":"41","author":"Mar\u00f4nek","year":"2025","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trecan.2025.10.001","article-title":"Mechanisms of whole-genome doubling in cancer evolution","volume":"12","author":"McKenney","year":"2026","journal-title":"Trends Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-020-2844-1","article-title":"Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency","volume":"588","author":"Mehdipour","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146246","article-title":"Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells","volume":"819","author":"Morales","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105621_bib65","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41467-018-04600-2","article-title":"ADAR1-mediated regulation of melanoma invasion","volume":"9","author":"Nemlich","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11918-7","article-title":"ADAR1 as a prognostic marker for patients with colorectal cancer and synchronous liver metastasis and a predictor of chemotherapy efficacy","volume":"15","author":"Nitta","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib67","first-page":"1","article-title":"Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer","author":"Okugawa","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105621_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","article-title":"Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors","volume":"13","author":"Paz-Yaacov","year":"2015","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib69","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.trecan.2019.09.010","article-title":"CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer","volume":"5","author":"Pereira","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib70","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","article-title":"Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development","volume":"43","author":"Pestal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105621_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gendis.2022.03.011","article-title":"Prognostic value of the RNA editing enzyme: ADAR1, and its association with immune cells infiltration in pancreatic adenocarcinoma","volume":"10","author":"Qi","year":"2023","journal-title":"Genes. Dis."},{"key":"10.1016\/j.critrevonc.2026.105621_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib74","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer - role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-021-01333-7","article-title":"CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing","volume":"20","author":"Shen","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41375-024-02500-7","article-title":"ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis","volume":"39","author":"Shi","year":"2025","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105621_bib77","article-title":"AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer","volume":"3","author":"Shigeyasu","year":"2018","journal-title":"JCI Insight Jun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib78","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-021-21921-x","article-title":"ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells","volume":"12","author":"Shiromoto","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ncb3110","article-title":"Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis","volume":"17","author":"Shoshan","year":"2015","journal-title":"Nat. Cell. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105621_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114618","article-title":"An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation","volume":"43","author":"Sinigaglia","year":"2024","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105621_bib81","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","article-title":"TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment","volume":"49","author":"Sun","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2026.105621_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.116952","article-title":"ADAR1 regulates radiosensitivity in ESCC through cIAP2-NF-\u03baB signaling and C16orf46 editing","volume":"29","author":"Sun","year":"2026","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105621_bib83","first-page":"148","article-title":"The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc","volume":"10","author":"Sun","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105621_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.12.009","article-title":"Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fi broblasts in colorectal cancer","volume":"444","author":"Takeda","year":"2019","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105621_bib85","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/biology11040568","article-title":"Self or Non-Self? It Is also a Matter of RNA Recognition and Editing by ADAR1","volume":"11","author":"Tassinari","year":"2022","journal-title":"Biology"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105621_bib86","article-title":"ADAR1 expression is associated with cervical cancer progression and negatively regulates NK cell activity","volume":"10","author":"Tassinari","year":"2025","journal-title":"JCI Insight Jul."},{"key":"10.1016\/j.critrevonc.2026.105621_bib87","first-page":"471","article-title":"ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad18","volume":"48","author":"Tian","year":"2025","journal-title":"Cell. Oncol. (Dordrecht Netherlands)"},{"key":"10.1016\/j.critrevonc.2026.105621_bib88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105621_bib89","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-025-02312-y","article-title":"ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer","volume":"24","author":"Umeda","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib90","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1093\/nar\/gkae700","article-title":"ADARp150 counteracts whole genome duplication","volume":"52","author":"van Gemert","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2026.105621_bib91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41467-018-02851-7","article-title":"A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression","volume":"9","author":"Velazquez-Torres","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105621_bib92","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","article-title":"Apoptotic stress causes mtDNA release during senescence and drives the SASP","volume":"622","author":"Victorelli","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-025-00718-6","article-title":"A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC","volume":"30","author":"Wang","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105621_bib94","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.2147\/CMAR.S210504","article-title":"ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway","volume":"11","author":"Xiao","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2026.105621_bib95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12672-024-01462-7","article-title":"A-to-I-edited miR-1251-5p restrains tumor growth and metastasis in lung adenocarcinoma through regulating TCF7-mediated Wnt signaling pathway","volume":"15","author":"Xu","year":"2024","journal-title":"Discov. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105621_bib96","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1002\/cam4.6044","article-title":"ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105621_bib97","first-page":"1469","article-title":"ADAR1 p110 Enhances Adhesion of Tumor Cells to Extracellular Matrix in Hepatocellular Carcinoma via Up-Regulating ITGA2 Expression","volume":"25","author":"Yu","year":"2019","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105621_bib98","article-title":"Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Immunother. Cancer Oct."},{"key":"10.1016\/j.critrevonc.2026.105621_bib99","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105621_bib100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12915-025-02310-y","article-title":"Adar contributes to genome integrity by regulating R-loop homeostasis in Drosophila","volume":"23","author":"Zhang","year":"2025","journal-title":"BMC Biol."},{"key":"10.1016\/j.critrevonc.2026.105621_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7620181","article-title":"A Comprehensive and Systematic Analysis Revealed the Role of ADAR1 in Pan-Cancer Prognosis and Immune Implications","author":"Zhu","year":"2023","journal-title":"Dis. Markers Feb 21"},{"key":"10.1016\/j.critrevonc.2026.105621_bib102","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","article-title":"The senescence journey in cancer immunoediting","volume":"23","author":"Zingoni","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105621_bib103","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3389\/fimmu.2017.01194","article-title":"Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance","volume":"8","author":"Zingoni","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:51:14Z","timestamp":1793087474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":103,"alternative-id":["S1040842826005081"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105621","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAR1 promotes cancer fitness by buffering endogenous RNA sensing","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105621"}}